DocDollars

Aquestive Therapeutics, Inc.

NJ · United States · Reporting entity ID 100000501813

Total reported 2019–2025
$5.62M
#673 of 2,960 reporting companies — 0% of all reported industry payments
$1.29M in general payments across 7,969 records, plus $4.33M in research funding across 457 records.

How it breaks down

General payments $1,286,210
Research funding $4,331,018

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Aquestive Therapeutics, Inc. reported $5.62M to US doctors and teaching hospitals from 2019 to 2025, ranking #673 of 2,960 reporting companies. 77% of that was research funding and 23% general payments such as consulting, speaking, food and travel. 7,969 general payment records and 457 research records were filed.

Common questions about Aquestive Therapeutics, Inc.

How much has Aquestive Therapeutics, Inc. paid US doctors?

Aquestive Therapeutics, Inc. reported $5,617,228 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,286,210 in general payments, $4,331,018 in research funding.

How does Aquestive Therapeutics, Inc. rank among drug and device companies?

It ranks #673 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Aquestive Therapeutics, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.